On June 1, 2022 Taiho Pharmaceutical Co., Ltd. reported that it will donate a total of 4.17 million yen in matching gift to three projects for the first Taiho Smile Support, a program to support organizations and individuals working to solve social issues in the field of oncology (Press release, Taiho, JUN 1, 2022, View Source [SID1234615312]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Taiho Pharmaceutical planned the first Taiho Smile Support to contribute to Goal 3 of the SDGs: "Ensure healthy lives and promote well-being for all at all ages." It then called for projects to address various issues surrounding cancer. Three projects were selected from among the many applications, and all three applicants succeeded in crowdfunding their goal amounts. Taiho Pharmaceutical’s donation, totaling 4.17 million yen, represents 50% of the total funds needed to implement the three projects. Each project will be gradually implemented.
Yokohama Children’s Hospice
UMI TO SORA NO OUCHI (a home of sea and sky): "Connecting Through Green" Project
Through this program, Taiho Pharmaceutical aims to support the dreams of organizations and individuals who are working to address challenges in the field of oncology. In partnership with these organizations, individuals, and all of the people who support them via crowdfunding, Taiho Pharmaceutical seeks to create a world where the precious moments of everyday life keep flowing for people with cancer and their families.
First Taiho Smile Support (Available only in Japanese)
Taiho Smile Support is an initiative to support organizations and individuals seeking to solve various social issues in the field of oncology that cannot be solved by drugs alone. Taiho Pharmaceutical called for organizations and individuals who plan to use crowdfunding to raise funds to address these social issues. The selected organizations and individuals each conducted a crowdfunding campaign and reached their funding target.* They will each receive from Taiho Pharmaceutical, in the form of a donation, matching funds equal to the target they have raised.
* The crowdfunding target (not including the crowdfunding fee) is to be 50% of all funds needed to carry out the project. If the target is met, Taiho Pharmaceutical will provide the remaining 50%. Thus, the success of the crowdfunding campaign will determine whether or not Taiho Pharmaceutical will provide support.